Matthew Z Dudley1,2, Rupali J Limaye1,2,3,4,5, Daniel A Salmon1,2,3, Saad B Omer6,7,8,9, Sean T O'Leary10,11, Mallory K Ellingson7, Christine I Spina10, Sarah E Brewer10,12, Robert A Bednarczyk13,14,15, Fauzia Malik8, Paula M Frew16,17, Allison T Chamberlain14. 1. 25802 Department of International Health, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. 2. 1466 Institute for Vaccine Safety, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. 3. Department of Health, Behavior and Society, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. 4. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. 5. International Vaccine Access Center, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD, USA. 6. 12228 Yale Institute for Global Health, Yale School of Medicine, New Haven, CT, USA. 7. Department of Infectious Diseases, Yale School of Medicine, New Haven, CT, USA. 8. Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA. 9. Department of Health Policy and Management, Yale School of Public Health, New Haven, CT, USA. 10. 129263 Adult and Child Consortium for Health Outcomes Research and Delivery Science, University of Colorado Anschutz Medical Campus and Children's Hospital Colorado, Aurora, CO, USA. 11. Department of Pediatrics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 12. Department of Family Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 13. 25798 Hubert Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA. 14. 1371 Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, USA. 15. Emory Vaccine Center, Emory University, Atlanta, GA, USA. 16. 14722 School of Community Health Sciences and Office of Research and Economic Development, University of Nevada, Las Vegas, NV, USA. 17. Population Health & Health Equity Initiative, University of Nevada, Las Vegas, NV, USA.
Abstract
OBJECTIVES: Although disparities in maternal vaccine acceptance among racial/ethnic groups are well documented, the reasons for these disparities are unclear. The objective of this study was to describe differences in pregnant women's knowledge, attitudes, beliefs, intentions, and trust regarding maternal and infant vaccines by race/ethnicity. METHODS: We collected survey data from 1862 pregnant women from diverse prenatal care practices in Georgia and Colorado from June 2017 through July 2018. We performed multiple logistic regressions to determine differences in intentions, knowledge, attitudes, beliefs, and trust by race/ethnicity and calculated odds ratios (ORs) and 95% CIs. RESULTS: Compared with White women, Black and Hispanic women were less confident in vaccine safety and efficacy and less likely to perceive risk of acquiring vaccine-preventable diseases, report provaccine social norms, indicate having enough vaccine knowledge, and trust vaccine information from health care providers and public health authorities. Black women were the least confident in the safety of the maternal influenza vaccine (OR = 0.37; 95% CI, 0.27-0.49); maternal tetanus, diphtheria, and acellular pertussis vaccine (OR = 0.37; 95% CI, 0.27-0.52); and infant vaccines overall (OR = 0.40; 95% CI, 0.28-0.58), and were least likely to intend to receive both maternal vaccines (OR = 0.35; 95% CI, 0.27-0.47) or all infant vaccines on time (OR = 0.45; 95% CI, 0.34-0.61) as compared with White women. CONCLUSIONS: Understanding differences in behavioral constructs integral to vaccine decision making among women of different races/ethnicities can lead to tailored interventions to improve vaccine acceptance.
OBJECTIVES: Although disparities in maternal vaccine acceptance among racial/ethnic groups are well documented, the reasons for these disparities are unclear. The objective of this study was to describe differences in pregnant women's knowledge, attitudes, beliefs, intentions, and trust regarding maternal and infant vaccines by race/ethnicity. METHODS: We collected survey data from 1862 pregnant women from diverse prenatal care practices in Georgia and Colorado from June 2017 through July 2018. We performed multiple logistic regressions to determine differences in intentions, knowledge, attitudes, beliefs, and trust by race/ethnicity and calculated odds ratios (ORs) and 95% CIs. RESULTS: Compared with White women, Black and Hispanic women were less confident in vaccine safety and efficacy and less likely to perceive risk of acquiring vaccine-preventable diseases, report provaccine social norms, indicate having enough vaccine knowledge, and trust vaccine information from health care providers and public health authorities. Black women were the least confident in the safety of the maternal influenza vaccine (OR = 0.37; 95% CI, 0.27-0.49); maternal tetanus, diphtheria, and acellular pertussis vaccine (OR = 0.37; 95% CI, 0.27-0.52); and infant vaccines overall (OR = 0.40; 95% CI, 0.28-0.58), and were least likely to intend to receive both maternal vaccines (OR = 0.35; 95% CI, 0.27-0.47) or all infant vaccines on time (OR = 0.45; 95% CI, 0.34-0.61) as compared with White women. CONCLUSIONS: Understanding differences in behavioral constructs integral to vaccine decision making among women of different races/ethnicities can lead to tailored interventions to improve vaccine acceptance.
Authors: Douglas J Opel; Rita Mangione-Smith; James A Taylor; Carolyn Korfiatis; Cheryl Wiese; Sheryl Catz; Diane P Martin Journal: Hum Vaccin Date: 2011-04-01
Authors: Indu B Ahluwalia; Helen Ding; Denise D'Angelo; Kristen H Shealy; James A Singleton; Jennifer Liang; Kenneth D Rosenberg Journal: MMWR Morb Mortal Wkly Rep Date: 2015-05-22 Impact factor: 17.586
Authors: María Isabel Fernández-Cano; Antonia Arreciado Marañón; Azahara Reyes-Lacalle; Maria Feijoo-Cid; Josep Maria Manresa-Domínguez; Laura Montero-Pons; Rosa Maria Cabedo-Ferreiro; Pere Toran-Monserrat; Gemma Falguera-Puig Journal: Int J Environ Res Public Health Date: 2022-04-06 Impact factor: 3.390